Search research articles
Contact Us
Filters
Showing results (41-50 of 721) with videos related to
Page
of 73
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 22, 2022
Tackling the Last Mile: A Major Component to Successfully Establish Radioligand Therapy
Kelsey L Pomykala, Marcus Würker, Ken Herrmann
Endocrine
|
June 19, 2015
Visualization of tumor heterogeneity in neuroendocrine tumors by positron emission tomography
Constantin Lapa, Rudolf A Werner, Ken Herrmann
European Journal of Nuclear Medicine and Molecular Imaging
|
March 29, 2011
PET/CT for staging lung cancer: costly or cost-saving?
Andreas K Buck, Ken Herrmann, Jonas Schreyögg
Nuklearmedizin. Nuclear Medicine
|
April 29, 2020
Impact of COVID-19 on Nuclear Medicine in Germany, Austria and Switzerland: An International Survey in April 2020
Lutz S Freudenberg, Ulf Dittmer, Ken Herrmann
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 30, 2024
Oncologist, Business Leader, and Investor Arie S. Belldegrun Discusses a Career in Innovative Medical Entrepreneurship: A Conversation with Ken Herrmann and Johannes Czernin
Arie S Belldegrun, Ken Herrmann, Johannes Czernin
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 2023
Advancing Clinical Trial Innovation in Pancreatic Cancer: A Conversation Between Diane Simeone, Ken Herrmann, and Johannes Czernin
Diane M Simeone, Ken Herrmann, Johannes Czernin
International Journal of Molecular Sciences
|
February 15, 2022
Chaperone Therapy in Fabry Disease
Frank Weidemann, Ana Jovanovic, Ken Herrmann, et al.
PET Clinics
|
April 30, 2023
Fibroblast Activation Protein as a Diagnostic and Therapeutic Target: Where Do We Go from Here?
Rodney J Hicks, Frederik L Giesel, Ken Herrmann
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2026
Targeted Radiopharmaceutical Therapy: Advances, Investment Dynamics, and Future Directions-Part 1
Catello Somma, Richard Zimmermann, Germo Gericke, et al.
Deutsches Arzteblatt International
|
March 29, 2018
CUP Syndrome-Metastatic Malignancy with Unknown Primary Tumor
Gregor Zaun, Martin Schuler, Ken Herrmann, et al.
Page
of 73
Search research articles
Search
Showing results (41-50 of 721) with videos related to
Sort By:
Page
of 73
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 22, 2022
Tackling the Last Mile: A Major Component to Successfully Establish Radioligand Therapy
Kelsey L Pomykala, Marcus Würker, Ken Herrmann
Endocrine
|
June 19, 2015
Visualization of tumor heterogeneity in neuroendocrine tumors by positron emission tomography
Constantin Lapa, Rudolf A Werner, Ken Herrmann
European Journal of Nuclear Medicine and Molecular Imaging
|
March 29, 2011
PET/CT for staging lung cancer: costly or cost-saving?
Andreas K Buck, Ken Herrmann, Jonas Schreyögg
Nuklearmedizin. Nuclear Medicine
|
April 29, 2020
Impact of COVID-19 on Nuclear Medicine in Germany, Austria and Switzerland: An International Survey in April 2020
Lutz S Freudenberg, Ulf Dittmer, Ken Herrmann
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 30, 2024
Oncologist, Business Leader, and Investor Arie S. Belldegrun Discusses a Career in Innovative Medical Entrepreneurship: A Conversation with Ken Herrmann and Johannes Czernin
Arie S Belldegrun, Ken Herrmann, Johannes Czernin
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 2023
Advancing Clinical Trial Innovation in Pancreatic Cancer: A Conversation Between Diane Simeone, Ken Herrmann, and Johannes Czernin
Diane M Simeone, Ken Herrmann, Johannes Czernin
International Journal of Molecular Sciences
|
February 15, 2022
Chaperone Therapy in Fabry Disease
Frank Weidemann, Ana Jovanovic, Ken Herrmann, et al.
PET Clinics
|
April 30, 2023
Fibroblast Activation Protein as a Diagnostic and Therapeutic Target: Where Do We Go from Here?
Rodney J Hicks, Frederik L Giesel, Ken Herrmann
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2026
Targeted Radiopharmaceutical Therapy: Advances, Investment Dynamics, and Future Directions-Part 1
Catello Somma, Richard Zimmermann, Germo Gericke, et al.
Deutsches Arzteblatt International
|
March 29, 2018
CUP Syndrome-Metastatic Malignancy with Unknown Primary Tumor
Gregor Zaun, Martin Schuler, Ken Herrmann, et al.
Page
of 73